171 related articles for article (PubMed ID: 18286288)
1. Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.
Ma Z; Molavi O; Haddadi A; Lai R; Gossage RA; Lavasanifar A
Cancer Chemother Pharmacol; 2008 Dec; 63(1):27-35. PubMed ID: 18286288
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol analogue 3,4,4',5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells.
Piotrowska H; Myszkowski K; Ziółkowska A; Kulcenty K; Wierzchowski M; Kaczmarek M; Murias M; Kwiatkowska-Borowczyk E; Jodynis-Liebert J
Toxicol Appl Pharmacol; 2012 Aug; 263(1):53-60. PubMed ID: 22687606
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
4. 3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.
Piotrowska-Kempisty H; Ruciński M; Borys S; Kucińska M; Kaczmarek M; Zawierucha P; Wierzchowski M; Łażewski D; Murias M; Jodynis-Liebert J
Sci Rep; 2016 Sep; 6():32627. PubMed ID: 27585955
[TBL] [Abstract][Full Text] [Related]
5. Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue.
Piotrowska H; Myszkowski K; Amarowicz R; Murias M; Kulcenty K; Wierzchowski M; Jodynis-Liebert J
Toxicol In Vitro; 2013 Dec; 27(8):2127-34. PubMed ID: 24055891
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.
Sale S; Tunstall RG; Ruparelia KC; Potter GA; Steward WP; Gescher AJ
Int J Cancer; 2005 Jun; 115(2):194-201. PubMed ID: 15688382
[TBL] [Abstract][Full Text] [Related]
7. The Effect of 4'-hydroxy-3,4,5-trimetoxystilbene, the Metabolite of Resveratrol Analogue DMU-212, on Growth, Cell Cycle and Apoptosis in DLD-1 and LOVO Colon Cancer Cell Lines.
Jozkowiak M; Skupin-Mrugalska P; Nowicki A; Borys-Wojcik S; Wierzchowski M; Kaczmarek M; Ramlau P; Jodynis-Liebert J; Piotrowska-Kempisty H
Nutrients; 2020 May; 12(5):. PubMed ID: 32392733
[TBL] [Abstract][Full Text] [Related]
8. Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency.
Androutsopoulos VP; Ruparelia KC; Papakyriakou A; Filippakis H; Tsatsakis AM; Spandidos DA
Eur J Med Chem; 2011 Jun; 46(6):2586-95. PubMed ID: 21497957
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein.
Kotha A; Sekharam M; Cilenti L; Siddiquee K; Khaled A; Zervos AS; Carter B; Turkson J; Jove R
Mol Cancer Ther; 2006 Mar; 5(3):621-9. PubMed ID: 16546976
[TBL] [Abstract][Full Text] [Related]
10. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle.
Pozo-Guisado E; Alvarez-Barrientos A; Mulero-Navarro S; Santiago-Josefat B; Fernandez-Salguero PM
Biochem Pharmacol; 2002 Nov; 64(9):1375-86. PubMed ID: 12392819
[TBL] [Abstract][Full Text] [Related]
11. Heteroaromatic analogs of the resveratrol analog DMU-212 as potent anti-cancer agents.
Penthala NR; Thakkar S; Crooks PA
Bioorg Med Chem Lett; 2015 Jul; 25(14):2763-7. PubMed ID: 26022840
[TBL] [Abstract][Full Text] [Related]
12. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
Gibson LF; Fortney J; Magro G; Ericson SG; Lynch JP; Landreth KS
Breast Cancer Res Treat; 1999 May; 55(2):107-17. PubMed ID: 10481938
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.
Sale S; Verschoyle RD; Boocock D; Jones DJ; Wilsher N; Ruparelia KC; Potter GA; Farmer PB; Steward WP; Gescher AJ
Br J Cancer; 2004 Feb; 90(3):736-44. PubMed ID: 14760392
[TBL] [Abstract][Full Text] [Related]
14. Role of CYP1A1 in the biological activity of methylated resveratrol analogue, 3,4,5,4'-tetramethoxystilbene (DMU-212) in ovarian cancer A-2780 and non-cancerous HOSE cells.
Piotrowska-Kempisty H; Klupczyńska A; Trzybulska D; Kulcenty K; Sulej-Suchomska AM; Kucińska M; Mikstacka R; Wierzchowski M; Murias M; Baer-Dubowska W; Kokot Z; Jodynis-Liebert J
Toxicol Lett; 2017 Feb; 267():59-66. PubMed ID: 28049037
[TBL] [Abstract][Full Text] [Related]
15. Steroidogenic activity of liposomal methylated resveratrol analog 3,4,5,4'-tetramethoxystilbene (DMU-212) in human luteinized granulosa cells in a primary three-dimensional in vitro model.
Józkowiak M; Kobylarek D; Bryja A; Gogola-Mruk J; Czajkowski M; Skupin-Mrugalska P; Kempisty B; Spaczyński RZ; Piotrowska-Kempisty H
Endocrine; 2023 Dec; 82(3):681-694. PubMed ID: 37572199
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes.
Mirzapur P; Khazaei MR; Moradi MT; Khazaei M
Life Sci; 2018 Jul; 205():45-53. PubMed ID: 29705353
[TBL] [Abstract][Full Text] [Related]
17. DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer.
Piotrowska H; Myszkowski K; Abraszek J; Kwiatkowska-Borowczyk E; Amarowicz R; Murias M; Wierzchowski M; Jodynis-Liebert J
Biomed Pharmacother; 2014 May; 68(4):397-400. PubMed ID: 24768110
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines.
Wolter F; Akoglu B; Clausnitzer A; Stein J
J Nutr; 2001 Aug; 131(8):2197-203. PubMed ID: 11481417
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization.
Schneider Y; Chabert P; Stutzmann J; Coelho D; Fougerousse A; Gossé F; Launay JF; Brouillard R; Raul F
Int J Cancer; 2003 Nov; 107(2):189-96. PubMed ID: 12949793
[TBL] [Abstract][Full Text] [Related]
20. G2/M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-4'-bromo-cis-stilbene, in human lung cancer cells.
Lee EJ; Min HY; Joo Park H; Chung HJ; Kim S; Nam Han Y; Lee SK
Life Sci; 2004 Oct; 75(23):2829-39. PubMed ID: 15464834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
